MedPath

An Open Clinical Trial to Assess the Influence of Newly Prescribed Aminobiphosphonates on Arterial Stiffness

Withdrawn
Conditions
Arteriosclerosis
Osteoporosis
Registration Number
NCT00180232
Lead Sponsor
Technische Universität Dresden
Brief Summary

The study tries to reveal if aminobisphosphonates influence aside the bone density also the vascular status in the typical elderly patient population

Detailed Description

The subjects - starting bisphosphonate treatment due to medical reasons - will be additionally investigated as outpatients (arterial stiffness, applanation tonometry), for each subject 3 individual dates with a duration of approx. 30 min each are scheduled, prior to therapy with bisphosphonate, after 3 and 6 month of treatment

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Patients starting an aminobisphosphonate therapy due to medical reasons Broca-index: between -20 and +25% who are willing and capable to confirm written consent to enrolment after ample information has been provided
Exclusion Criteria
  • patients with major cardiovascular disease patients participating in another clinical trial 1month prior to inclusion in this study patients unable or unwilling to give informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Medizinische Fakultät der Technischen Universität Dresden

🇩🇪

Dresden, Germany

© Copyright 2025. All Rights Reserved by MedPath